Trial
NCT01545635
RETIC Trial: Reversal of Trauma Induced Coagulopathy Using Coagulation Factor Concentrates or Fresh Frozen Plasma
Phase IIITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
Medical University Innsbruck
Collaborators
—
Condition
Major Trauma
Intervention
Fibrinogen concentrate, Prothrombin complex concentrate and FXIII concentrate
Why stopped
The Interim analysis (100 patients) revealed a possible harm to patients randomised to the fresh frozen plasma (FFP) treatment arm.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-03-23